odiparcil has been researched along with Eye Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, S; Cimbolini, N; Entchev, E; Feraille, L; Germain, JM; Jantzen, I; Lacombe, O; Luccarrini, JM; Mauro, V; Roussey, A; Tallandier, M; Young, SP; Zhang, H | 1 |
1 other study(ies) available for odiparcil and Eye Disorders
| Article | Year |
|---|---|
MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment.
Topics: Animals; Disease Models, Animal; Eye; Eye Diseases; Glycosides; Humans; Mice; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Phenotype | 2022 |